BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 26556851)

  • 21. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
    Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
    Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity.
    Krönig M; Walter M; Drendel V; Werner M; Jilg CA; Richter AS; Backofen R; McGarry D; Follo M; Schultze-Seemann W; Schüle R
    Oncotarget; 2015 Jan; 6(2):1302-14. PubMed ID: 25514598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous expression of tumor-associated genes in disseminated breast cancer cells.
    Zieglschmid V; Hollmann C; Gutierrez B; Krehan A; Kaul S; Böcher O
    Anticancer Res; 2007; 27(4A):1769-76. PubMed ID: 17649771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods.
    Hillig T; Horn P; Nygaard AB; Haugaard AS; Nejlund S; Brandslund I; Sölétormos G
    Tumour Biol; 2015 Jun; 36(6):4597-601. PubMed ID: 25608842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
    Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
    Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
    Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
    BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
    Ge F; Zhang H; Wang DD; Li L; Lin PP
    Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
    Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
    Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Size-selective collection of circulating tumor cells using Vortex technology.
    Sollier E; Go DE; Che J; Gossett DR; O'Byrne S; Weaver WM; Kummer N; Rettig M; Goldman J; Nickols N; McCloskey S; Kulkarni RP; Di Carlo D
    Lab Chip; 2014 Jan; 14(1):63-77. PubMed ID: 24061411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM
    Lampignano R; Yang L; Neumann MHD; Franken A; Fehm T; Niederacher D; Neubauer H
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.
    Weissenstein U; Schumann A; Reif M; Link S; Toffol-Schmidt UD; Heusser P
    BMC Cancer; 2012 May; 12():206. PubMed ID: 22646670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
    Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
    BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
    Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
    Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells.
    Lu NN; Xie M; Wang J; Lv SW; Yi JS; Dong WG; Huang WH
    ACS Appl Mater Interfaces; 2015 Apr; 7(16):8817-26. PubMed ID: 25853336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
    Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
    Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers.
    Hristozova T; Konschak R; Budach V; Tinhofer I
    Cytometry A; 2012 Jun; 81(6):489-95. PubMed ID: 22438318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The challenge of gene expression profiling in heterogeneous clinical samples.
    Rodrıguez-Gonzalez FG; Mustafa DA; Mostert B; Sieuwerts AM
    Methods; 2013 Jan; 59(1):47-58. PubMed ID: 22652627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.
    Wang G; Benasutti H; Jones JF; Shi G; Benchimol M; Pingle S; Kesari S; Yeh Y; Hsieh LE; Liu YT; Elias A; Simberg D
    Colloids Surf B Biointerfaces; 2018 Jan; 161():200-209. PubMed ID: 29080504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.